The influence of cardiopulmonary bypass on pediatric pharmacokinetics

Area of Science:

• Pediatric cardiac surgery
• Pharmacokinetics
• Cardiopulmonary bypass

Background:

• Thousands of children undergo surgery for congenital heart disease annually.
• Cardiac surgery necessitates cardiopulmonary bypass (CPB), which can unpredictably affect drug pharmacokinetics.
• Understanding these effects is crucial for safe and effective medication management in pediatric patients.

Purpose of the Study:

• To review the pathophysiological effects of CPB on pharmacokinetic parameters in pediatric patients.
• To summarize recent literature (last 10 years) on CPB and pediatric pharmacokinetics.
• To highlight the need for improved pharmacokinetic modeling in this population.

Main Methods:

• Literature search of PubMed using keywords: 'Cardiopulmonary bypass', 'Pediatric', 'Pharmacokinetics'.
• Inclusion of studies published within the last 10 years.
• Review of related articles and reference lists for relevant studies.

Main Results:

• Increased interest in CPB's influence on pharmacokinetics, particularly with population pharmacokinetic modeling.
• Current study designs often limit the power to obtain comprehensive pharmacokinetic data.
• The optimal method for modeling CPB's pharmacokinetic impact remains undetermined.

Conclusions:

• More research is required on the pathophysiology of pediatric heart disease and CPB.
• Validated pharmacokinetic models integrated into electronic databases could enable real-time drug concentration prediction.
• Such models would facilitate bedside guidance for individualized patient management and drug therapy.